Walleye Capital’s BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock PHGE.U Stock Holding History

Walleye Capital’s Portfolio PHGE.U Stock Details PHGE.U Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,269	Closed	-$2.66K	–	6053
2024 Q2	$2.66K	Hold	1,269	–	–	﹤0.01%	5397
2024 Q1	$4.44K	Hold	1,269	–	–	﹤0.01%	5173
2023 Q4	$5.07K	Hold	1,269	–	–	﹤0.01%	4652
2023 Q3	$3.93K	Hold	1,269	–	–	﹤0.01%	4629
2023 Q2	$4.19K	Hold	1,269	–	–	﹤0.01%	4056
2023 Q1	$3.05K	Sell	1,269 -750	-37%	-$2.59K	﹤0.01%	3721
2022 Q4	$4.44K	Hold	2,019	–	–	﹤0.01%	2873
2022 Q3	$13K	Buy	+2,019	New	+$18.2K	﹤0.01%	2791

Other funds holding PHGE.U

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Walleye Capital's PHGE.U Position: Q3 2024 in Review

Walleye Capital sold out of BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock (PHGE.U) in Q3 2024, closing a stake of 1,269 shares — an estimated $2.66K sold.

Walleye Capital first reported a position in PHGE.U in Q3 2022 and held it in 8 quarters. The position peaked at $13K in Q3 2022. 2 funds tracked by Wall St. Rank hold PHGE.U as of Q3 2024.

Walleye Capital reported no remaining BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock position as of Q3 2024 after selling out during the quarter.
Walleye Capital sold 1,269 BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock shares in Q3 2024, an estimated $2.66K.
Walleye Capital first reported a position in BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock in Q3 2022 and held it in 8 quarters.
Walleye Capital's BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock position peaked at $13K in Q3 2022.
2 funds tracked by Wall St. Rank held BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock as of Q3 2024.

Based on Walleye Capital's 13F filing for Q3 2024, filed 14 Nov 2024.